Dashboard
Manage Tickers

RARE


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
'Biogen Is Pursuing More Dealmaking This Y...
06/27/2024 15:39:59

https://endpts.com/biogen-is-pursuing-more-dealmaking-this-year-with-plans-to-spend-up-to-8B/  

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

reported-earlier-ultragenyx-prices-350m-public-offering-of-7435898-common-shares-at-39share-and-pre-funded-warrants
Reported Earlier, Ultragenyx Prices $350M ...
06/14/2024 06:27:39

In addition, in lieu of issuing common stock to certain investors, the company is offering pre-funded warrants to purchase 1,53...

dave--busters-posts-downbeat-results-joins-jjill-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Dave & Buster's Posts Downbeat Results, Jo...
06/13/2024 09:51:52

ultragenyx-pharmaceutical-commences-350m-public-offering-of-common-stock-and-pre-funded-warrants
Ultragenyx Pharmaceutical Commences $350M ...
06/12/2024 20:07:39

ultragenyx-plans-to-file-for-accelerated-approval-of-ux111-for-the-treatment-of-sanfilippo-syndrome-type-a-after-meeting-with-fda
Ultragenyx Plans To File For Accelerated A...
06/12/2024 20:00:59

Agreement reached with FDA that cerebral spinal fluid (CSF) heparan sulfate (HS) can be used as a reasonable surrogate endpoint...

cantor-fitzgerald-reiterates-overweight-on-ultragenyx-pharmaceutical-maintains-115-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:19:34

Cantor Fitzgerald analyst Kristen Kluska reiterates Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and maintains ...

Core News & Articles
Ultragenyx, Mereo Report 14-Month Results ...
06/11/2024 21:53:19

As of a May 24, 2024 data cut-off date, treatment with setrusumab (UX143) continued to significantly reduce incidence of fractu...

this-united-airlines-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday
This United Airlines Analyst Turns Bullish...
06/06/2024 13:58:12

goldman-sachs-upgrades-ultragenyx-pharmaceutical-to-buy-raises-price-target-to-67
Goldman Sachs Upgrades Ultragenyx Pharmace...
06/06/2024 13:03:53

Goldman Sachs analyst Salveen Richter upgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) from Neutral to Buy and raises the pr...

wedbush-maintains-neutral-on-ultragenyx-pharmaceutical-raises-price-target-to-48
Wedbush Maintains Neutral on Ultragenyx Ph...
05/31/2024 17:39:50

Wedbush analyst Laura Chico maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Neutral and raises the price target fro...

b-of-a-securities-maintains-buy-on-ultragenyx-pharmaceutical-lowers-price-target-to-76
B of A Securities Maintains Buy on Ultrage...
05/31/2024 17:01:19

B of A Securities analyst Tazeen Ahmad maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and lowers the price tar...

canaccord-genuity-maintains-buy-on-ultragenyx-pharmaceutical-raises-price-target-to-111
Canaccord Genuity Maintains Buy on Ultrage...
05/31/2024 16:59:54

Canaccord Genuity analyst Whitney Ijem maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price tar...

cantor-fitzgerald-maintains-overweight-on-ultragenyx-pharmaceutical-raises-price-target-to-115
Cantor Fitzgerald Maintains Overweight on ...
05/31/2024 14:36:14

Cantor Fitzgerald analyst Kristen Kluska maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the ...

peeling-back-the-layers-exploring-ultragenyx-pharmaceutical-through-analyst-insights
Peeling Back The Layers: Exploring Ultrage...
05/31/2024 14:00:47

stifel-maintains-buy-on-ultragenyx-pharmaceutical-raises-price-target-to-127
Stifel Maintains Buy on Ultragenyx Pharmac...
05/31/2024 13:28:05

Stifel analyst Dae Gon Ha maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $124...

baird-maintains-outperform-on-ultragenyx-pharmaceutical-raises-price-target-to-72
Baird Maintains Outperform on Ultragenyx P...
05/31/2024 12:16:16

Baird analyst Joel Beatty maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Outperform and raises the price target fr...

ultragenyx-announces-top-line-results-from-phase-3-study-of-dtx401-gene-therapy-for-glycogen-storage-disease-type-ia
Ultragenyx Announces Top-Line Results From...
05/30/2024 20:00:59

Treatment with DTX401 resulted in a statistically significant reduction in daily cornstarch intake at Week 48 (p<0.0001) wit...

ultragenyx-faces-lawsuit-over-alleged-unjust-use-of-henrietta-lacks-cells
Ultragenyx Faces Lawsuit Over Alleged Unju...
05/22/2024 16:27:00

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken wit...

canaccord-genuity-maintains-buy-on-ultragenyx-pharmaceutical-lowers-price-target-to-109
Canaccord Genuity Maintains Buy on Ultrage...
05/06/2024 17:35:29

Canaccord Genuity analyst Whitney Ijem maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and lowers the price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)